Brazil has approved a new law to partially prohibit live animal testing for cosmetics, and will instead prioritize ...
Independent DSMB reports zero device-related safety issuesSupports potential clinical benefitTrial sample size re-estimated to strengthen ...
In a now-completed clinical trial, the stem cell therapy Neuronata-R was found to benefit ALS patients with slower disease ...
Objectives The development of simple tools to identify individuals at high risk of coronary heart disease (CHD) would enable rapid implementation of preventive measures. This study was designed to ...
This article explores innovative drug delivery strategies, including DNA barcoding, shape-engineered nanoparticles and ...
FDA Approves Guselkumab as First IL-23 Inhibitor with Both SC and IV Induction Options for UC and CD
The FDA has approved a subcutaneous (SC) induction regimen of guselkumab (Tremfya) for adults with moderately to severely ...
Researchers have uncovered new evidence that challenges long-standing beliefs about asymptomatic malaria infections. The study, led by Monash University’s Professor Diana Hansen, focused on Plasmodium ...
Horsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved a subcutaneous (SC) ...
Objectives C reactive protein (CRP) is frequently normal in psoriatic arthritis (PsA) despite active disease, complicating ...
Trinity College Dublin scientists showed that electrical stimulation reprograms macrophages to reduce inflammation and boost healing. This breakthrough could lead to broad therapeutic uses.
A new pediatric asthma attack prediction model combines data on attack history, salivary bacteria composition, and serum inflammatory mediator levels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback